Ambroxol lozenge bioavailability - An open-label, two-way crossover study of the comparative bioavailability of ambroxol lozenges and commercial tablets in healthy Thai volunteers

被引:9
|
作者
Rojpibulstit, M [1 ]
Kasiwong, S [1 ]
Juthong, S [1 ]
Phadoongsombat, N [1 ]
Faroongsarng, D [1 ]
机构
[1] Prince Songkla Univ, Fac Pharmaceut Sci, Songkhla, Thailand
关键词
D O I
10.2165/00044011-200323040-00007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To compare the bioavailability of two 15mg ambroxol lozenges with a commercial 30mg ambroxol tablet. Design: Open-label, two-way crossover study. Method: Each formulation was randomly administered to 20 healthy Thai volunteers (ten male and ten female) with a 1-week washout period between formulations. After administration, serial blood samples were collected over a 24-hour period and the plasma concentration of ambroxol was subsequently measured using high performance liquid chromatography with ultraviolet detection after liquid-liquid extraction. Pharmacokinetic parameters were analysed by a noncompartmental pharmacokinetic model and compared between formulations using analysis of variance with a significance level of 0.05. Results: The point estimates (90% CI) of the area under the plasma concentration-time curve (AUC) and peak plasma concentration (C-max) ratios between lozenge and commercial tablet were 1.07 (0.89 to 1.28) and 1.20 (1.04 to 1.40), respectively. The point estimate (90% CI) of the difference between formulations for time to C-max was 0.40 (-0.20 to 1.00). Conclusion: The two formulations under test were not bioequivalent based on the stipulated bioequivalence criteria. The biclavailability from the ambroxol lozenge might be better, since the 90% CI of the AUC(0-infinity) fell outside the bioequivalence range, and its range was narrower. The difference in rate of absorption was not conclusive because ambroxol was delivered from the lozenge by two parallel processes, namely absorption via oral and gastrointestinal mucosa. The additional oral mucosal absorption might not only contribute more absorption but also introduce variability compared with that of tablet administration. The relative importance of oral versus gastrointestinal mucosal absorption of ambroxol from the lozenge formulation, and the clinical significance of this, requires further study.
引用
下载
收藏
页码:273 / 280
页数:8
相关论文
共 50 条
  • [21] Bioequivalence and pharmacokinetics of two zidovudine formulations in healthy Brazilian volunteers: An open-label, randomized, single-dose, two-way crossover study
    dos Reis Serra, Cristina Helena
    Mori Koono, Eunice Emiko
    Kano, Eunice Kazue
    Schramm, Simone Grigoleto
    Armando, Yara Popst
    Porta, Valentina
    CLINICAL THERAPEUTICS, 2008, 30 (05) : 902 - 908
  • [22] Pharmacokinetics and relative bioavailability of sitagliptin hydrochloride and sitagliptin phosphate tablets formulations: a randomized, open-label, crossover in male volunteers
    Leong, Chuei Wuei
    Sagim, Elton
    Yee, Kar Ming
    Saharuddin, Muhammad Shalhadi
    Rahim, Sharifah Radziah Syed Abd
    Sabri, Khairil
    Jamaluddin, Mohd Zulhairi
    Ahmad, Shahnun
    Amran, Atiqah
    Tayyem, Rabab F.
    GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2023, 12 (01): : 12 - 16
  • [23] SYSTEMIC BIOAVAILABILITY OF DICLOFENAC DIETHYLAMINE 2.32% GEL VERSUS ORAL DICLOFENAC SODIUM TABLETS (50 MG) IN HEALTHY VOLUNTEERS: A RANDOMIZED, OPEN-LABEL, CROSSOVER STUDY
    Armogida, M.
    Gold, M.
    Golor, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1189 - 1189
  • [24] Comparative bioavailability of two formulations of terbinafine -: Data from a cross-over, randomised, open-label bioequivalence study in healthy volunteers
    Almeida, S
    Filipe, A
    Vallée, F
    Tanguay, M
    Larouche, R
    Lainesse, A
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2004, 54 (11): : 757 - 762
  • [25] Comparative Safety, Bioavailability, and Pharmacokinetics of Oral Dexamethasone, 4-mg and 20-mg Tablets, in Healthy Volunteers Under Fasting and Fed Conditions: A Randomized Open-label, 3-way Crossover Study
    Bashir, Qaiser
    Acosta, Mark
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (11): : 768 - 773
  • [26] A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults
    Park, Kyungsoo
    Kim, Yu Seun
    Kwon, Kwang-il
    Park, Min Soo
    Lee, Yoon Jung
    Kim, Kyung Hwan
    CLINICAL THERAPEUTICS, 2007, 29 (01) : 154 - 162
  • [27] Relative bioavailability and pharmacokinetics of a new sibutramine formulation in healthy male subjects: A randomized, open-label, two-period, comparative crossover study
    Park, JY
    Kim, KA
    Park, PW
    Suh, KH
    Lee, GS
    CLINICAL THERAPEUTICS, 2004, 26 (12) : 2092 - 2101
  • [28] COMPARATIVE RANDOMIZED, SINGLE DOSE, TWO-WAY CROSSOVER, OPEN-LABEL STUDY TO DETERMINE THE BIOEQUIVALENCE OF IRBESARTAN FORMULATION, IRBESARTAN GPO 150 MG TABLETS AND APROVEL (R) 150 MG TABLETS, AFTER ORAL ADMINISTRATION TO HEALTHY THAI VOLUNTEERS UNDER FASTING CONDITIONS
    Yoosakul, Ekawan
    Seeduang, Charinthon
    Chuasuwan, Bancha
    Manamuti, Chutima
    Pitisuttithum, Punnee
    Karachot, Busarat
    Techatanawat, Isariya
    JOURNAL OF HEALTH RESEARCH, 2016, 30 (03) : 199 - 205
  • [29] Comparative Bioavailability of 2 Tablet Formulations of Levodopa/Benserazide in Healthy, Fasting Volunteers: A Single-Dose, Randomized-Sequence, Open-Label Crossover Study
    Keller, Guillermo A.
    Czerniuk, Paola
    Bertuola, Roberto
    Spatz, Juan G.
    Assefi, Aria R.
    Di Girolamo, Guillermo
    CLINICAL THERAPEUTICS, 2011, 33 (04) : 500 - 510
  • [30] Comparative crossover, randomized, open-label bioequivalence study on the bioequivalence of two formulations of thioctic acid in healthy volunteers
    Mignini, Fiorenzo
    Streccioni, Valentino
    Tomassoni, Daniele
    Traini, Enea
    Amenta, Francesco
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2007, 29 (08) : 575 - 586